| Date Filed | Type | Description |
| 06/09/2023 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,550 shares
@ $0
Granted 4,250 options to buy
@ $76.58, valued at
$325.5k
|
|
| 06/13/2019 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $58.74, valued at
$293.7k
|
|
| 06/20/2018 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 5,000 options to buy
@ $80.69, valued at
$403.5k
|
|
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2017 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,875 shares
@ $0
Granted 3,750 options to buy
@ $65.66, valued at
$246.2k
|
|
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/14/2016 |
4
| NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 525,000 options
@ $4.02, valued at
$2.1M
Granted 105,000 options
@ $4.02, valued at
$422.1k
Granted 315,000 options
@ $15, valued at
$4.7M
Granted 63,000 options
@ $15, valued at
$945k
|
|
| 06/14/2016 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,875 shares
@ $0
Granted 3,750 options to buy
@ $65.85, valued at
$246.9k
|
|
| 06/02/2016 |
4
| NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 8,777 shares
@ $0.34, valued at
$3k
|
|
| 02/04/2016 |
4
| NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 721 shares
@ $4.17, valued at
$3k
Granted 1,761 shares
@ $2.03, valued at
$3.6k
Granted 700,000 options to buy
@ $1.78, valued at
$1.2M
Granted 800,000 rights
@ $0 |
|
| 06/22/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2015 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Celladon Corp|
Txns:
| Granted 10,000 options to buy
@ $2.16, valued at
$21.6k
|
|
| 02/24/2015 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 17,500 options to buy
@ $55.57, valued at
$972.5k
|
|
| 02/05/2015 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 635,150 options to buy
@ $5.34, valued at
$3.4M
|
|
| 09/15/2014 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $4.782, valued at
$239.1k
|
|
| 05/21/2014 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Celladon Corp|
Txns:
| Granted 10,000 options to buy
@ $9.58, valued at
$95.8k
|
|
| 02/11/2014 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 3,980 shares
@ $5.34, valued at
$21.3k
Granted 673,500 options to buy
@ $6.3, valued at
$4.2M
|
|
| 02/06/2014 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Celladon Corp|
Txns:
| Bought 62,500 shares
@ $8, valued at
$500k
|
|
| 05/24/2013 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 3,800 shares
@ $0
Granted 7,600 options to buy
@ $21.94, valued at
$166.7k
|
|
| 02/19/2013 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 555,000 options to buy
@ $5.69, valued at
$3.2M
|
|
| 07/19/2012 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 124,238 shares
@ $7.66, valued at
$951.7k
Sold 25,762 shares
@ $7.66, valued at
$197.3k
Exercised 124,238 options to buy
@ $1.66, valued at
$206.2k
Exercised 25,762 options to buy
@ $1.7, valued at
$43.8k
|
|
| 07/13/2012 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 2,900 shares
@ $6.66, valued at
$19.3k
Sold 147,100 shares
@ $6.7, valued at
$985.6k
Exercised 2,900 options to buy
@ $1.66, valued at
$4.8k
Exercised 147,100 options to buy
@ $1.66, valued at
$244.2k
|
|
| 06/29/2012 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 100,000 shares
@ $5.66, valued at
$566k
Sold 125,000 shares
@ $6.08, valued at
$760k
Exercised 100,000 options to buy
@ $1.66, valued at
$166k
Exercised 125,000 options to buy
@ $1.66, valued at
$207.5k
|
|
| 05/29/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2012 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 7,600 options
@ $13.3, valued at
$101.1k
Granted 3,800 restricted stock units
@ $0 |
|
| 01/26/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/26/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2011 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 7,600 options
@ $15.41, valued at
$117.1k
Granted 3,800 restricted stock units
@ $0 |
|
| 03/04/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2010 |
4
| NARACHI MICHAEL (President and CEO) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 142,650 options to buy
@ $5.89, valued at
$840.2k
|
|
|